Bidding 10-12 Feb 2025, price band ₹151–159, lot 800 shares.
After allotment
Chandan Healthcare operates a large diagnostic network in North India, with extensive pathology and radiology services across Jaipur, Uttar Pradesh, and Uttarakhand. As of December 31, 2024, the company has processed over 55.79 lakh tests from about 17.11 lakh patients, mainly generating 70.04% of its revenue from Uttar Pradesh. The network includes one flagship lab, nine central labs, and various accredited centres, offering 1,496 test types. Significant revenue streams come from B2B, B2G, and B2C segments, supported by a cluster-based model for efficiency. Additionally, its subsidiary, Chandan Pharmacy Limited, enhances revenue through sales of pharmaceuticals and FMCG across 31 stores.